Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish

Leukemia

Volumn 27, Issue 9, 2013, Pages 1913-1917

  Sun, J ^a   Liu, W ^a   Li, L ^b   Chen, J ^a   Wu, M ^a   Zhang, Y ^a   Leung, A Y H ^c   Zhang, W ^a   Wen, Z ^d   Liao, W ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHWEST UNIVERSITY   (China)

^c QUEEN MARY HOSPITAL   (Hong Kong)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; LYSOZYME; PEROXIDASE; TRANSCRIPTION FACTOR PU 1;

APOPTOSIS; BONE MARROW CELL; CELL EXPANSION; CELL PROLIFERATION; ENZYME ACTIVITY; HEMATOPOIETIC TISSUE; IN SITU HYBRIDIZATION; LETTER; LOSS OF FUNCTION MUTATION; MACROPHAGE; MYELOPOIESIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; ZEBRA FISH;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; MUTATION; MYELOPOIESIS; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; ZEBRAFISH;

EID: 84883741096     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.67     Document Type: Letter

References (15)

1. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994; 265: 1573-1577.
2. Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003; 4: 1029-1036. (Pubitemid 37265925)
3. Jin H, Li L, Xu J, Zhen F, Zhu L, Liu PP et al. Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression. Blood 2012; 119: 5239-5249.
4. Dakic A, Wu L, Nutt SL. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 2007; 28: 108-114. (Pubitemid 46283693)
5. Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet 2006; 38: 1269-1277. (Pubitemid 44646289)
6. Zhu X, Zhang H, Qian M, Zhao X, Yang W, Wang P et al. The significance of low PU.1 expression in patients with acute promyelocytic leukemia. J Hematol Oncol 2012; 5: 22.
7. Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2002; 100: 998-1007. (Pubitemid 34832629)
8. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 2004; 36: 624-630. (Pubitemid 38715991)
9. Metcalf D, Dakic A, Mifsud S, Di Rago L, Wu L, Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci USA 2006; 103: 1486-1491. (Pubitemid 43191192)
10. Stoletov K, Klemke R. Catch of the day: zebrafish as a human cancer model. Oncogene 2008; 27: 4509-4520.
11. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008; 132: 631-644. (Pubitemid 351260057)
12. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med 2005; 201: 1487-1502. (Pubitemid 40664092)
13. Pigneux A, Perreau V, Jourdan E, Vey N, Dastugue N, Huguet F et al. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results. Haematologica 2007; 92: 1327-1334. (Pubitemid 350153468)
14. Rabbani A, Finn RM, Ausio J. The anthracycline antibiotics: antitumor drugs that alter chromatin structure. Bioessays 2005; 27: 50-56. (Pubitemid 40128622)
15. Anderson KL, Smith KA, Pio F, Torbett BE, Maki RA. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 1998; 92: 1576-1585. (Pubitemid 28406861)